Hisashi Yamanaka

Professor

Tokyo Women's Medical University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hisashi Yamanaka is a Professor at Tokyo Women's Medical University in Japan. His research primarily focuses on the management of rheumatoid arthritis, including drug treatment algorithms, treatment adherence during the COVID-19 pandemic, and the efficacy of biologic therapies. His recent publications highlight the safety, immunogenicity, and cost-effectiveness of treatments, as well as the impact of comorbid conditions on patient outcomes.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Naoto Tamura

Associate Professor

Juntendo University

JAPAN

View details

Mitsumasa Kishimoto

JAPAN

View details

Ayako Shoji

University of Tokyo

JAPAN

View details

Naohiro Sugitani

Mie University Hospital

JAPAN

View details

KATSUNORI IKARI

Professor (Fixed term)

Tokyo Women's Medical University

JAPAN

View details

Hiromu Ito

Associate Professor

Kyoto University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hisashi Yamanaka

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication

Lower injection-site reactions and long-term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113: Results from a post-hoc analysis of a double-blind, randomized, phase III comparative study and its open-label extension in patients with rheumatoid arthritis

Non-drug and surgical treatment algorithm and recommendations for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication

Changes in treatment adherence and behaviour during the COVID-19 pandemic in Japanese patients with rheumatoid arthritis: Results from cross-sectional study in the IORRA cohort

Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data

Differences in patients' population and efficacy/effectiveness of biologic disease-modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis - using the IORRA cohort

Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study)

Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases

Factors associated with frailty in Japanese patients with rheumatoid arthritis: results from the Institute of Rheumatology Rheumatoid Arthritis cohort study

Impact of concomitant chronic kidney disease on hospitalised infections and remission in patients with rheumatoid arthritis: results from the IORRA cohort

Collaborators (6)

Naoto Tamura

Mitsumasa Kishimoto

Ayako Shoji

Naohiro Sugitani

KATSUNORI IKARI

Hiromu Ito

Make your next move.